Your browser doesn't support javascript.
loading
Risk of atrial fibrillation with use of oral and intravenous bisphosphonates.
Sharma, Abhishek; Einstein, Andrew J; Vallakati, Ajay; Arbab-Zadeh, Armin; Walker, Marcella Donovan; Mukherjee, Debabrata; Homel, Peter; Borer, Jeffrey S; Lichstein, Edgar.
Afiliação
  • Sharma A; Department of Medicine, Maimonides Medical Center, Brooklyn, New York. Electronic address: abhisheksharma4mamc@gmail.com.
  • Einstein AJ; Division of Cardiology, Department of Medicine, Columbia University Medical Center and NewYork-Presbyterian Hospital, New York, New York; Department of Radiology, Columbia University Medical Center and NewYork-Presbyterian Hospital, New York, New York.
  • Vallakati A; Division of Cardiology, University of Kansas Medical Center, Kansas City, Kansas.
  • Arbab-Zadeh A; Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Walker MD; Division of Endocrinology, Department of Medicine, Columbia University Medical Center, New York, New York.
  • Mukherjee D; Division of Cardiology, Texas Tech University, El Paso, Texas.
  • Homel P; Division of Statistics, Maimonides Medical Center, Brooklyn, New York.
  • Borer JS; Division of Cardiovascular Medicine and The Howard Gilman Institute for Heart Valve Disease, State University of New York Downstate Medical Center, Brooklyn, New York.
  • Lichstein E; Department of Medicine, Maimonides Medical Center, Brooklyn, New York.
Am J Cardiol ; 113(11): 1815-21, 2014 Jun 01.
Article em En | MEDLINE | ID: mdl-24837258
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Difosfonatos Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Difosfonatos Idioma: En Ano de publicação: 2014 Tipo de documento: Article